243 related articles for article (PubMed ID: 28561694)
21. Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?
Geisler C; Kolstad A; Laurell A; Räty R; Nordic Lymphoma Group ; Mantle Cell Lymphoma Subcommittee
Leuk Lymphoma; 2009 Aug; 50(8):1249-56. PubMed ID: 19562619
[TBL] [Abstract][Full Text] [Related]
22. Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.
Dreyling M; Hoster E; Bea S; Hartmann E; Horn H; Hutter G; Salaverria I; Pott C; Trneny M; Le Gouill S; Cortelazzo S; Szymczyk M; Jurczak W; Shpilberg O; Ribrag V; Hermine O;
Leuk Lymphoma; 2010 Sep; 51(9):1612-22. PubMed ID: 20629519
[TBL] [Abstract][Full Text] [Related]
23. Open questions in the management of mantle cell lymphoma.
Li ZM; Zucca E; Ghielmini M
Cancer Treat Rev; 2013 Oct; 39(6):602-9. PubMed ID: 23415066
[TBL] [Abstract][Full Text] [Related]
24. The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?
Dreyling M; Ferrero S;
Haematologica; 2016 Feb; 101(2):104-14. PubMed ID: 26830211
[TBL] [Abstract][Full Text] [Related]
25. Results from the Belgian mantle cell lymphoma registry.
Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A
Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652
[TBL] [Abstract][Full Text] [Related]
26. Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop.
Williams ME; Dreyling MH; Kahl BS; Leonard JP; O'Connor OA; Press OW; Wilson WH
Leuk Lymphoma; 2010 Mar; 51(3):390-8. PubMed ID: 20038219
[TBL] [Abstract][Full Text] [Related]
27. [Mantle cell lymphoma: Towards a personalized therapeutic strategy?].
Navarro Matilla B; García-Marco JA
Med Clin (Barc); 2015 Jun; 144(12):553-9. PubMed ID: 25023849
[TBL] [Abstract][Full Text] [Related]
28. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
Dreyling M; Kluin-Nelemans HC; Beà S; Klapper W; Vogt N; Delfau-Larue MH; Hutter G; Cheah C; Chiappella A; Cortelazzo S; Pott C; Hess G; Visco C; Vitolo U; Klener P; Aurer I; Unterhalt M; Ribrag V; Hoster E; Hermine O;
Leuk Lymphoma; 2013 Apr; 54(4):699-707. PubMed ID: 23020649
[TBL] [Abstract][Full Text] [Related]
29. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Dreyling M; Hiddemann W
Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
[TBL] [Abstract][Full Text] [Related]
30. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
Dreyling M; Kluin-Nelemans HC; Beà S; Hartmann E; Salaverria I; Hutter G; Perez-Galan P; Roue G; Pott C; Le Gouill S; Cortelazzo S; Rule S; Hess G; Zaja F; Vitolo U; Szymczyk M; Walewski J; Ribrag V; Unterhalt M; Hermine O; Hoster E;
Leuk Lymphoma; 2011 Dec; 52(12):2226-36. PubMed ID: 21851218
[TBL] [Abstract][Full Text] [Related]
31. Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop.
Kahl BS; Gordon LI; Dreyling M; Gascoyne RD; Sotomayor EM
Leuk Lymphoma; 2015; 56(9):2505-11. PubMed ID: 25944379
[TBL] [Abstract][Full Text] [Related]
32. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
Virchows Arch; 2016 Oct; 469(4):471-6. PubMed ID: 27457074
[TBL] [Abstract][Full Text] [Related]
33. Treatment of mantle cell lymphoma: current approach and future directions.
Brody J; Advani R
Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
[TBL] [Abstract][Full Text] [Related]
34. Therapies for mantle cell lymphoma: current challenges and a brighter future.
Skarbnik AP; Smith MR
Discov Med; 2013 Mar; 15(82):177-87. PubMed ID: 23545046
[TBL] [Abstract][Full Text] [Related]
35. Mantle cell lymphoma: evolving management strategies.
Campo E; Rule S
Blood; 2015 Jan; 125(1):48-55. PubMed ID: 25499451
[TBL] [Abstract][Full Text] [Related]
36. [Current therapeutic strategies for mantle cell lymphoma].
Dreyling M; Schnaiter A; Schmidt C; Hoster E
Internist (Berl); 2016 Mar; 57(3):230-7. PubMed ID: 26886710
[TBL] [Abstract][Full Text] [Related]
37. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
Avivi I; Goy A
Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
[TBL] [Abstract][Full Text] [Related]
38. Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.
Condoluci A; Rossi D; Zucca E; Cavalli F
Curr Oncol Rep; 2018 Aug; 20(10):79. PubMed ID: 30132080
[TBL] [Abstract][Full Text] [Related]
39. Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation.
Nazeef M; Kahl BS
Curr Treat Options Oncol; 2015 Jun; 16(6):29. PubMed ID: 25975443
[TBL] [Abstract][Full Text] [Related]
40. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]